Palliative chemo harming end-stage cancer patients

Oncologists are facing criticism for administering chemotherapy to patients with end-stage cancer despite little evidence of its benefit.

US cancer specialists are calling for no active treatment to be the default option for patients who are expected to die in the next six months.

The calls are based on a recent study of 300 US patients with end-stage metastatic cancer and a life expectancy of less